Nakul M Shah

7PUBLICATIONS
47CO-AUTHORS
Molecular targetsNeural engineeringEpigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 18, 2026
Proteogenomic profiling identifies FGFR2b as a prevalent cell-surface target in intrahepatic cholangiocarcinoma.

|Jul 24, 2026
Antibody-drug conjugates in solid tumors: Efficacy, challenges, and opportunities.

|Sep 02, 2024
Epigenetic therapy potentiates transposable element transcription to create tumor-enriched antigens in glioblastoma cells.

H Josh Jang, Nakul M Shah, Ju Heon Maeng

|Feb 12, 2024
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities.

Yi-Zhou Jiang, Ding Ma, Xi Jin

|Jan 16, 2024
Towards targeting transposable elements for cancer therapy.

Yonghao Liang, Xuan Qu, Nakul M Shah

|Mar 27, 2023
Pan-cancer analysis identifies tumor-specific antigens derived from transposable elements.

Nakul M Shah, H Josh Jang, Yonghao Liang

Pageof 2

Frequent Collaborators

5 joint publications

Ting Wang

3 joint publications

Ju Heon Maeng

3 joint publications

Yonghao Liang

2 joint publications

Hyung Joo Lee